CRISPR™ MDCKII cell lines development for bioavailability and DDI assessments

090424_DTR Webinar_Non Branded Image

Join this webinar to hear from Eurofins Discovery on the latest offerings for drug-drug interaction assessments using CRISPR KO/KI MDCKII cell lines